FORXIGAâ„¢ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes

[at noodls] – AstraZeneca and Bristol-Myers Squibb Company today announced that the European Commission has approved FORXIGAâ„¢ (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union (EU). … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard